Scopus by Title (Ref)
Articles that cite the referenced work, matched by title from the Scopus database.
Protein-Protein Interaction as an Efficient Target to Inhibit HIV-1 Integrase
Archiv Der Pharmazie
May 2026
Zarghi A.
Design, synthesis, molecular dynamics studies and biological evaluations of 4-hydroxy-5-pyrrolinone-3-carbohydrazides as HIV-1 integrase inhibitors
European Journal of Medicinal Chemistry Reports
December 2024
Karimi N.
Open Access
Computational investigation of Y. aloifolia variegate as anti-Human Immunodeficiency Virus (HIV) targeting HIV-1 protease: A multiscale in-silico exploration
Pharmacological Research Modern Chinese Medicine
June 2024
Irsal R.A.P.
Open Access
Comprehensive Review on Different Analytical Techniques for HIV 1- Integrase Inhibitors: Raltegravir, Dolutegravir, Elvitegravir and Bictegravir
Critical Reviews in Analytical Chemistry
2024
Jain P.
A Literature Review Focusing on the Antiviral Activity of [1,2,4] and [1,2,3]-triazoles
Mini Reviews in Medicinal Chemistry
2024
Farghaly T.A.
Recent Developments in the Synthesis of HIV-1 Integrase Strand Transfer Inhibitors Incorporating Pyridine Moiety
International Journal of Molecular Sciences
June 2023
Starosotnikov A.M.
Open Access
Repurposing FDA-approved drugs as HIV-1 integrase inhibitors: an in silico investigation
Journal of Biomolecular Structure and Dynamics
2023
Ha C.H.X.
Design, Synthesis, Docking Studies, and Biological Evaluation of Novel 2-Hydroxyacetophenone Derivatives as Anti-HIV-1 Agents
Current HIV Research
2023
Oliaie S.S.
A Korean Post-Marketing Surveillance Study of Dolutegravir Single-Agent Tablets in Patients with HIV-1
Infection and Chemotherapy
December 2022
Kwon S.
Open Access
Synthesis, Biological Evaluation, and Molecular Modeling Studies of New 8-methyl-4-oxo-1,4-dihydroquinoline-3-carbohydrazides as Potential Anti-HIV Agents
Iranian Journal of Pharmaceutical Research
Dec 2022
Alemi M.
Open Access
Design, Synthesis, Docking Study, and Biological Evaluation of 4-hydroxy-2-oxo-1,2-dihydroquinoline-3-carbohydrazide Derivatives as Anti-HIV-1 and Antibacterial Agents.
Iranian Journal of Pharmaceutical Research
Dec 2022
Abdollahi O.
Open Access
Chalcone-amide, a privileged backbone for the design and development of selective SARS-CoV/SARS-CoV-2 papain-like protease inhibitors
European Journal of Medicinal Chemistry
5 October 2022
Valipour M.
All Open Access, Green
Design, Synthesis, and Docking Studies of Thioimidazolyl Diketoacid Derivatives Targeting HIV-1 Integrase
Medicinal Chemistry
May 2022
Karimi N.
Non-nucleoside structured compounds with antiviral activity—past 10 years (2010–2020)
European Journal of Medicinal Chemistry
5 March 2022
Denel-Bobrowska M.
All Open Access, Green
Piroxicam Analogs: Design, Synthesis, Docking Study and Biological Evaluation as Promising Anti-HIV-1 Agents
Medicinal Chemistry
February 2022
Imani A.
Design, Synthesis and Docking studies of New Quinazolinone Derivatives as Anti-HIV-1 Agents
Iranian Journal of Pharmaceutical Sciences
2022
Zebardast T.
Novel 2-(Diphenylmethylidene) Malonic Acid Derivatives as Anti-HIV Agents: Molecular Modeling, Synthesis and Biological Evaluation
Iranian Journal of Pharmaceutical Research
Jan 2022
Lotfaliei M.
Open Access
Recent advances in small-molecule HIV-1 integrase inhibitors
Current Medicinal Chemistry
July 2021
Zhang C.
Design, Synthesis, Docking Study and Biological Evaluation of 4-Hydroxy-2H-benzo[e][1,2]thiazine-3-carboxamide 1,1-dioxide Derivatives as Anti-HIV Agents
Iranian Journal of Pharmaceutical Research
July 2021
Imani A.
First report for the electrochemical investigation of a new HIV integrase inhibitor dolutegravir: Its voltammetric determination in tablet dosage forms and human urine using a boron-doped diamond electrode
Diamond and Related Materials
April 2021
Allahverdiyeva S.
HIV-1 Reverse Transcriptase/Integrase Dual Inhibitors: A Review of Recent Advances and Structure-activity Relationship Studies
Iranian Journal of Pharmaceutical Research
Spring 2021
Mahboubi-Rabbani M.
Search for new therapeutics against HIV-1 via dual inhibition of RNase H and integrase: Current status and future challenges
Future Medicinal Chemistry
February 2021
Kharkwal H.
Development and genetic drug resistance research of HIV-1 integrase inhibitors
China Tropical Medicine
2021
Liang M.R.
Evaluating the effectiveness of recommended HIV adult postexposure prophylaxis drug regimens by using fuzzy PROMETHEE
Applications of Multi Criteria Decision Making Theories in Healthcare and Biomedical Engineering
1 January 2021
Uzun B.